Viasys Looks To Spur Growth Through Small Orthopedics Acquisitions
This article was originally published in The Gray Sheet
Executive Summary
Viasys Healthcare aims to lay the groundwork for Medicare reimbursement of its nitric oxide wound care therapy by 2006, when the device is expected to receive FDA approval